Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA accepts Camurus' NDA for CAM-2038 buprenorphine depots

Sep. 19, 2017

FDA grants priority review to Braeburn's NDA for CAM-2038 for opioid use disorder

Sep. 18, 2017

CHMP adopts positive opinion for Zubsolv as treatment of opioid dependence

Sep. 18, 2017

Ophirex licenses sPLA2 inhibitor data from Lilly and Shionogi to support snakebite program

Aug. 29, 2017

Pluristem starts pilot study to test PLX-R18 cell therapy for acute radiation syndrome

Aug. 17, 2017

Soligenix receives additional NIAID funding for the development of heat stable ricin vaccine

Aug. 16, 2017

Takeda Pharmaceutical presents novel mGluR7 agonists

Aug. 16, 2017

FDA accepts Achieve's IND for cytisine for smoking cessation

Aug. 11, 2017

Amygdala Neurosciences initiates phase Ib study of ALDH2 inhibitor

Aug. 2, 2017

Emergent BioSolutions' development of auto-injector for nerve agent antidote gets financial support

Aug. 1, 2017

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...